跳至主要内容
临床试验/NCT02583958
NCT02583958Unknown不适用

Assessment of Efficacy and Safety for a New Wound Dressing URGO 310 3166 in the Local Treatment of Venous or Mixed Leg Ulcers: A European, Randomised Clinical Trial

Laboratoires URGO2 个研究点 分布在 1 个国家开始时间: 2014年10月最近更新:
适应症

试验速览

阶段
不适用
试验地点
2
主要终点
Relative regression of wound surface area

研究概览

简要总结

Assessment of efficacy and safety for a new wound dressing URGO 310 3166 in the local treatment of venous or mixed leg ulcers: a European, randomised clinical trial.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patient over 18 years old who has provided his/her written informed consent,
  • Patient who can be monitored by the same investigation team throughout the whole duration of the study,
  • Patient who agrees to wear an effective venous compression system every day, associated with the trial dressing,
  • Leg ulcer with an Ankle Brachial Pressure Index (ABPI) not less than 0.7 and not more than 1.3,
  • Ulcer area > or equal to 5cm2,
  • Ulcer duration > or equal to 6 months,
  • Ulcer presenting a the surface wound bed covered with 50% or more by sloughy tissue,
  • Moderately or heavily exudative ulcers.

排除标准

  • Clinical infection on the wound bed.

结局指标

主要结局

Relative regression of wound surface area

时间窗: week 20

次要结局

  • Percentage of debrided wounds(at each clinical evaluation up to 20 weeks)
  • Patient's Quality of Life(at inclusion visit and at week 20 or at the end of study treatment)
  • Occurrence of adverse events as assessed by the investigator according to a classification MedDRA(between inclusion and week 20)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验